MEDIPOST Co. Ltd (078160) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.054x

Based on the latest financial reports, MEDIPOST Co. Ltd (078160) has a cash flow conversion efficiency ratio of -0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-14.44 Billion ≈ $-9.78 Million USD) by net assets (₩265.17 Billion ≈ $179.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of MEDIPOST Co. Ltd to measure how much of total assets are equity-financed.

MEDIPOST Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how MEDIPOST Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 078160 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

MEDIPOST Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MEDIPOST Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AXON PARTNERS GRP EO -10 F:XE1	N/A
Talga Group Ltd F:TGX	-0.234x
Solborn Inc KQ:035610	-0.027x
Terns Pharmaceuticals Inc NASDAQ:TERN	-0.070x
Shotspotter Inc NASDAQ:SSTI	0.062x
CX Technology Corp TW:2415	0.037x
Hansol Holdings Co Ltd KO:004150	0.010x
Fuzetec Technology Co Ltd TWO:6642	0.011x

Annual Cash Flow Conversion Efficiency for MEDIPOST Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of MEDIPOST Co. Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 078160 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩252.60 Billion ≈ $171.18 Million	₩-37.27 Billion ≈ $-25.25 Million	-0.148x	-142.55%
2023-12-31	₩313.66 Billion ≈ $212.56 Million	₩-19.08 Billion ≈ $-12.93 Million	-0.061x	-76.79%
2022-12-31	₩179.97 Billion ≈ $121.96 Million	₩-6.19 Billion ≈ $-4.20 Million	-0.034x	-235.26%
2021-12-31	₩159.48 Billion ≈ $108.08 Million	₩4.06 Billion ≈ $2.75 Million	0.025x	+66.11%
2020-12-31	₩116.54 Billion ≈ $78.98 Million	₩1.78 Billion ≈ $1.21 Million	0.015x	-77.26%
2019-12-31	₩111.59 Billion ≈ $75.62 Million	₩7.51 Billion ≈ $5.09 Million	0.067x	+23.88%
2018-12-31	₩126.81 Billion ≈ $85.94 Million	₩6.89 Billion ≈ $4.67 Million	0.054x	+181.97%
2017-12-31	₩104.45 Billion ≈ $70.78 Million	₩-6.93 Billion ≈ $-4.69 Million	-0.066x	+23.49%
2016-12-31	₩143.31 Billion ≈ $97.12 Million	₩-12.42 Billion ≈ $-8.42 Million	-0.087x	-83.84%
2015-12-31	₩146.48 Billion ≈ $99.27 Million	₩-6.91 Billion ≈ $-4.68 Million	-0.047x	-270.60%
2014-12-31	₩117.34 Billion ≈ $79.52 Million	₩-1.49 Billion ≈ $-1.01 Million	-0.013x	-229.63%
2011-12-31	₩115.04 Billion ≈ $77.96 Million	₩1.13 Billion ≈ $765.03K	0.010x	--

About MEDIPOST Co. Ltd

KQ:078160 Korea Biotechnology & Medical Research

Market Cap

$86.93 Million

₩128.27 Billion KRW

Market Cap Rank

#19614 Global

#960 in Korea

Share Price

₩8340.00

Change (1 day)

+9.88%

52-Week Range

₩7520.00 - ₩28000.00

All Time High

₩72522.12